Nisonic
Nisonic AS is a Trondheim-based medical software company that develops the FAST-ICP deep learning platform, performing AI-based transorbital ultrasound analysis to non-invasively detect raised intracranial pressure for hospitals, trauma centers, and ultrasound device manufacturers.
- Company typePrivate
- Founded2017
- HeadquartersTrondheim, Norway
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What Nisonic does
Nisonic AS is a Norwegian medical software company, founded in 2017 and headquartered in Trondheim, that develops non-invasive methods for detecting raised intracranial pressure (ICP). Its core product is the FAST-ICP software, which applies deep learning to transorbital ultrasound images of the optic nerve sheath, quantifying both static (Optic Nerve Sheath Diameter, ONSD) and dynamic (Deformability Index, DI) biomarkers to predict ICP in under a minute without equipment calibration. The technology originated from a collaboration initiated in 2013 between SINTEF ultrasound engineers in Trondheim and neurosurgeons at the Red Cross War Memorial Children's Hospital, University of Cape Town, and is protected by pending patents covering the novel ONSD and DI measurement methods.
The company complements the software with the CE-marked Nisonic P-100 ultrasound system (cleared May 2021), an off-the-shelf device that hosts FAST-ICP and is deployed in limited numbers for clinical research. As of 2025 Nisonic had accumulated more than 200,000 ultrasound images, most with paired invasive ICP ground truth, used to train its neural networks, and had published clinical evidence validating the method in children, adults with traumatic brain injury, and adults with aneurysmal subarachnoid hemorrhage.
Commercially Nisonic operates a dual B2B model. The FAST-ICP software is being prepared for embedding as an app in established point-of-care ultrasound consoles for Europe and USA market launch, with revenue intended to come from licensing arrangements with ultrasound device manufacturers. Separately, the P-100 system generates modest hardware revenue from research hospitals. The company is privately held and founder-led, with a single disclosed seed financing from Hadean Ventures, Investinor, and SINTEF Venture AS in 2018.
Nisonic firmographics
Firmographics- Name
- Nisonic
- Legal name
- Nisonic AS
- Website
- https://nisonic.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Nisonic AS is a Trondheim-based medical software company that develops the FAST-ICP deep learning platform, performing AI-based transorbital ultrasound analysis to non-invasively detect raised intracranial pressure for hospitals, trauma centers, and ultrasound device manufacturers.
- Ownership category
- akta.pro rank
Nisonic industry classification
Industry- Product category
- Medical Imaging Software
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Medical Imaging AI (HDAAAEAH)
Keywords
Where Nisonic is headquartered
LocationHeadquarters
- HQ city
- Trondheim
- HQ country
- Norway
- HQ region
- Europe
Offices1 record
Markets served
Nisonic business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales
Revenue model
- FAST-ICP Software Licensing: The FAST-ICP software is intended to be installed as an App in ultrasound scanners including handheld ultrasound devices. Revenue will be generated through licensing arrangements with ultrasound device manufacturers.
- Nisonic P-100 Ultrasound System Sales: The CE-marked Nisonic P-100 ultrasound system is available in limited numbers for hospitals doing research on ICP.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
Nisonic product offering
Product offeringCore offering
Nisonic develops the FAST-ICP software, an AI-based platform that performs automated analysis of transorbital ultrasound images to predict intracranial pressure (ICP) non-invasively. The software measures Optic Nerve Sheath Diameter (ONSD) and the Deformability Index (DI) using deep learning models and is intended to be installed as an app on standard medical ultrasound consoles, including handheld devices. The company also markets the CE-marked Nisonic P-100 ultrasound system, an off-the-shelf device pre-loaded with the FAST-ICP software used for clinical research and data collection.
Product overview
Nisonic is a medical software company offering the FAST-ICP software platform for non-invasive detection of intracranial pressure (ICP) using transorbital ultrasound imaging and machine learning. The portfolio consists of the FAST-ICP Software as the core AI-powered analysis platform (which can be installed on Windows computers and standard ultrasound devices as an app), and the Nisonic P-100 as a CE-marked ultrasound hardware system pre-loaded with the software. The software transforms standard medical ultrasound consoles into devices capable of predicting intracranial pressure through automated measurements of optic nerve sheath diameter and deformability index.
Differentiator
Problem solved
Functional benefit
Brands
- FAST-ICP: Automated analysis software for transorbital ultrasound images to predict intracranial pressure using optic nerve sheath measurements.
- Nisonic P-100
Products and services
- FAST-ICP Software AI-based analysis software for transorbital ultrasound images that uses deep learning to automatically measure Optic Nerve Sheath Diameter (ONSD) and Deformability Index (DI) to predict intracranial pressure non-invasively. Designed to be installed as an app on Windows-based computers and standard medical ultrasound consoles, including handheld devices. Targeted at clinicians, hospitals, and ultrasound device manufacturers.
- Nisonic P-100 Ultrasound System CE-marked, off-the-shelf medical ultrasound system pre-loaded with the Nisonic FAST-ICP software, providing real-time image acquisition guidance and automated AI-based image processing for non-invasive ICP detection. Available in limited numbers for hospitals conducting research on intracranial pressure.
Quantifiable outcome
- Detects raised ICP with high sensitivity using automated ONSD measurements in SAH patients
- +2 more outcomes
Companies that use Nisonic
Customer profileNamed customers3 records
Segments2 records
Ideal customer profiles2 records
Nisonic technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature5 records
Nisonic partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- SINTEFcoreTechnology co-development partner from Trondheim, Norway. SINTEF engineers developed the core technology combining leading ultrasound expertise with clinical applications. The collaboration began in 2013 for the research and concept phase.
- Red Cross War Memorial Children's Hospital, University of Cape TowncoreClinical development partner for non-invasive ICP detection methods. Neurosurgeons at this hospital collaborated with SINTEF engineers since 2013 to develop the new method for detecting intracranial pressure.
- Oslo University HospitalcoreClinical research partner conducting trials. Started clinical study at Oslo University Hospital Ullevål in adults with Traumatic Brain Injury (2019-2020). New study initiated in 2023 at Rikshospitalet in adults with subarachnoid hemorrhage.
Scale indicators4 records
Recent moves6 records
Expansion highlights6 records
Nisonic competitors and assessment
Company assessmentDirect peers
- Infrascan: Developer of a handheld near-infrared spectroscopy device for non-invasive detection of intracranial hematomas in head trauma. Comparable to Nisonic as a non-invasive, point-of-care brain-injury assessment tool aimed at the same TBI patient population.
- BrainScope: Maker of EEG-based, non-invasive devices for objective assessment of traumatic brain injury and concussion at the point of care. Comparable to Nisonic in targeting rapid, non-invasive TBI triage and ICP-related decision support in emergency and military settings.
- NovaSignal (Neural Analytics): Commercializes an ultrasound-based, AI-guided transcranial Doppler platform for cerebral blood flow and intracranial assessment. Closely comparable to Nisonic as a non-invasive, AI-on-ultrasound neuro-diagnostic company pursuing similar OEM and clinical channels.
Emerging players
- Third Eye Diagnostics: Developed a non-invasive intracranial pressure and temperature monitor using a supracoronal acoustic sensor. Comparable to Nisonic in pursuing non-invasive ICP measurement as an alternative to invasive intraventricular catheters.
- Vivonics: Develops non-invasive and portable neuro-diagnostic technologies for head trauma and ICP assessment, including ultrasound-based approaches. Comparable as a small, research-driven non-invasive ICP/TBI player with overlapping clinical use cases.
- Branchpoint Technologies: Developer of wireless, implantable ICP monitor and related neuro-monitoring tools. Comparable to Nisonic in being an ICP-focused innovator, although it has historically emphasized miniaturized implants rather than pure non-invasive ultrasound.
Broad incumbents
- Raumedic: Established manufacturer of invasive intracranial pressure monitors and catheters used in neurocritical care. Comparable to Nisonic as the incumbent standard-of-care ICP monitoring vendor that a successful non-invasive alternative would displace.
- Integra LifeSciences (Codman): Major neurosurgery and neurocritical care device portfolio including invasive ICP monitoring systems (Codman). Comparable as a large incumbent whose installed invasive ICP products define the market Nisonic would need to convert.
- GE HealthCare: Global ultrasound equipment OEM with point-of-care and clinical ultrasound consoles. Comparable as a potential OEM partner or competitor that could either embed FAST-ICP on its consoles or develop in-house AI-based ICP/optic nerve analysis.
- Philips: Major medical imaging and point-of-care ultrasound vendor with AI-enabled clinical applications. Comparable as a likely OEM integration target for FAST-ICP and as a potential source of in-house competition in AI ultrasound analytics.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Nisonic social profiles
Digital presenceNisonic compliance and trust
Trust signalCompliance3 records
Nisonic financial estimates
Financial estimateRevenue estimate
Valuation estimate
Nisonic leadership team
Management profileNumber of profiles
Profiles1 record
Nisonic funding detail
Funding detailFunding overview
Funding rounds1 record
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Nisonic M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Nisonic
What does Nisonic do?
Nisonic develops the FAST-ICP software, an AI-based platform that performs automated analysis of transorbital ultrasound images to predict intracranial pressure (ICP) non-invasively. The software measures Optic Nerve Sheath Diameter (ONSD) and the Deformability Index (DI) using deep learning models and is intended to be installed as an app on standard medical ultrasound consoles, including handheld devices. The company also markets the CE-marked Nisonic P-100 ultrasound system, an off-the-shelf device pre-loaded with the FAST-ICP software used for clinical research and data collection.
Is Nisonic a public or private company?
Nisonic is a private company. It is classified as venture growth investor backed and is currently operating.
When was Nisonic founded?
Nisonic was founded in 2017. It employs 1 to 10 people.
Where is Nisonic based?
Nisonic is headquartered in Trondheim, Norway, in the Europe region.
How does Nisonic make money?
Two revenue lines are on record. FAST-ICP Software Licensing is the primary driver. The others are nisonic P-100 Ultrasound System Sales.
Who are Nisonic's main competitors?
Direct peers on record are Infrascan, BrainScope and NovaSignal (Neural Analytics). Emerging players are Third Eye Diagnostics, Vivonics and Branchpoint Technologies. Broad incumbents are Raumedic, Integra LifeSciences (Codman), GE HealthCare and Philips.
Does Nisonic have an API?
No public API is recorded for Nisonic.
What industry is Nisonic in?
Nisonic's product category is Medical Imaging Software. Its primary akta.pro industry code is HDAAAEAH, Medical Imaging AI. Its NAICS code is 334510 and its SIC code is 3841.